Compared with the lowest quartile , subjects in the fourth quartile of serum CRP had a higher risk of liver cancer incidence ( OR , 1.63 ; 95 % CI , 1.06-2 .51 ) , with a significant Ptrend across quartiles ( P = 0.01 ) .